Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-myc proto-oncogene protein is a transcription factor encoded by the *MYCN* gene. It plays a critical role in embryonic development and cell growth/division. Amplification or overexpression of *MYCN* is strongly associated with neuroblastoma and other cancers. Mutations or deletions are linked to Feingold syndrome type 1. It functions by dimerizing with other bHLH proteins to bind DNA and regulate target gene transcription. N-Myc is considered an important therapeutic target.
Indirect strategies include targeting mRNA or regulatory partners.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-myc proto-oncogene protein (N-Myc).